<DOC>
	<DOCNO>NCT02868138</DOCNO>
	<brief_summary>The aim single-center observational study evaluate quality life , clinical effectiveness , satisfaction pediatric young adult patient sickle cell disease receive hydroxyurea .</brief_summary>
	<brief_title>Study Hydroxyurea Treat Sickle Cell Disease</brief_title>
	<detailed_description>In study , 34 pediatric ( HbSS : n= 5 ; HbSβ0 : n= 29 ) 16 ( HbSS : n=5 ; HbSβ0 : n= 11 ) young adult adult patient sickle cell disease receive hydroxyurea least year participate . Upon receipt Informed Consent Form , Case Report Form , Demographic Data Collection Form , Child Health Questionnaire-Parent Form , Life Quality Survey Short Form-36 , Hydroxyurea Therapy Satisfaction Survey use obtain data effectiveness hydroxyurea therapy parameter may affect compliance treatment life quality participant . Regarding normal range , ferritin , hemoglobin A , A2 , F , S , platelet , mean corpuscular volume , erythrocyte distribution width , basophil percentage , monocyte , monocyte percentage , total bilirubin , direct bilirubin , C-reactive protein value high hemoglobin , hematocrit , erythrocyte value low patient . Our finding regard quality life satisfaction hydroxyurea therapy indicate patient sickle cell disease low score . Demographic , clinical , therapeutic variable well comorbid disease concomitant drug use consider together , finding suggest health quality compliance pediatric young adult patient therapy might low due sufficiently effective hydroxyurea therapy addition comorbidities , concomitant drug use , side effect .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>1 . Patients willing participate study 2 . Pediatric young adult patient 3 . Patients diagnose HbSS HbSβ0 sickle cell disease 4 . Patients receive hydroxyurea least year . 1 . Patients meet inclusion criterion 2 . Patients willing participate study 3 . Patients diagnose type anemia except HbSS HbSβ0 sickle cell disease 4 . Patients receive hydroxyurea least year 5 . Patients condition physical and/or mental difficulty may affect quality life 6 . Patients contrindication hydroxyurea</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Sickle cell disease</keyword>
	<keyword>Hydroxyurea</keyword>
	<keyword>Compliance</keyword>
</DOC>